Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.20.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets

    As of December 31,
    2019   2018
    USD In thousands
         
Net operating loss carry-forward Biomx Inc.     -       -  
Net operating loss carry-forward Biomx Ltd.     5,953       2,430  
Total deferred tax assets     5,953       2,430  
Valuation allowance     (5,953 )     (2,430 )
Net deferred tax assets   $ -     $ -  
Schedule of reconciliation of the federal statutory and effective tax rate

    As of December 31,  
    2019     2018  
    USD In thousands  
             
Statutory U.S. federal income tax rate     21 %     21 %
U.S. vs foreign tax rate differential     2       2  
Business Combination expenses     (3.1 )     -  
Valuation allowance     (19.9 )     (23 )
Effective tax rate     0 %     0 %